Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Cetuximab News Monitoring

Get by Email • RSS

Published on 12:57 GMT

Alliance trial shows dual immunotherapy improves progression-free survival in advanced squamous cell skin cancer

May 31, 2025 — A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating that the combination of avelumab and cetuximab improved progression-free survival (PFS) compared to avelumab alone in …

Source: EurekAlert! - Neutral
Published on 01:07 GMT

Investigational MK-1084 Demonstrates Antitumor Activity in Phase I Trial for Colorectal and Non-Small Cell Lung Cancers

Key takeaways Early-phase trial design should anticipate combination therapy pathways, as seen with MK-1084 across multiple arms. Safety and tolerability remain primary endpoints, even when exploring novel mutation-specific therapies like KRAS G12C …

Source: Applied Clinical Trials - Pending
Published on May 30, 2025

Precision Pfizer Drug Leads to ‘Unprecedented’ Survival in Colorectal Cancer, Data at ASCO Show

A precision oncology Pfizer drug now has clinical data showing it helped patients with colorectal cancer live longer, results that study investigators say could change the way physicians treat those whose disease exhibits the specific genetic signature …

Source: MedCity News - Neutral
Published on May 30, 2025

Advanced colon cancer patients lived twice as long with a Pfizer combo therapy, trial finds

A combination drug treatment doubled survival time for patients with an aggressive form of colorectal cancer, according to late-stage trial data published Friday in The New England Journal of Medicine and presented at the American Society of Clinical …

Source: NBC News - Center-left
Published on May 30, 2025

Balancing Disease Control and Adverse Effect Management: Expert Insights in CML Treatment

Encorafenib/Cetuximab With mFOLFOX6 Lengthens PFS in BRAF V600E+ mCRC Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma Acupuncture Use in BC Predicted by Social Determinants of Health Variability Found in PROs, Gene Expression …

Source: Oncology Nursing News - Pending
Published on May 30, 2025

Merck KANDLELIT Trials Spark Hope For Hard-To-Treat Cancers

Merck & Co Inc MRK on Friday shared safety and efficacy results from the open-label Phase 1 KANDLELIT-001 study of MK-1084 alone and in combination with other therapies. The study included patients with KRAS G12C-mutant solid tumors, advanced …

Source: Benzinga - Neutral
Published on May 30, 2025

Encorafenib/Cetuximab With mFOLFOX6 Lengthens PFS in BRAF V600E+ mCRC

The combination of encorafenib (Braftovi) and cetuximab (Erbitux) plus chemotherapy with mFOLFOX6 (modified fluorouracil, leucovorin, and oxaliplatin) yielded significant and clinically meaningful increase in progression-free survival (PFS) vs the standard …

Source: Oncology Nursing News - Pending
Published on May 29, 2025

Global Familial Adenomatous Polyposis FAP Treatment Market Forecast To Reach $2.31 Billion By 2029 With 11.4%

The Business Research Company’s Familial Adenomatous Polyposis Treatment Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /⁨EINPresswire.com⁩/ -- How Significant is the Growth in …

Distribution channels: Business & Economy, Companies ...
Published on May 28, 2025

Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer

The phase 1/2 ATR04-484 clinical trial is examining ATR-04 therapy for the treatment of EGFR inhibitor-associated rashes in patients with non-small cell lung cancer, colorectal cancer and others, according to a news release from Azitra, Inc., a …

Source: Cure Today - Neutral
Published on May 29, 2025

March Toward More Tailored Treatments Continues at ASCO 2025

The term “precision medicine” is hardly new. But this year’s annual gathering of the American Society of Clinical Oncology (ASCO) will highlight how directing treatments toward specific patients has reached a new level, guided by advances in therapy, …

Source: The American Journal of Managed Care - Neutral
Published on May 27, 2025

Global Familial Adenomatous Polyposis FAP Treatment Market Forecast: Growth Drivers, Trends & Opportunities 2025–2034

The Business Research Company’s Adenomatous Polyposis FAP Treatment Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 27, 2025 /⁨EINPresswire.com⁩/ -- The Business Research …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025

Braftovi and Erbitux Plus Chemo Improves Outcomes for BRAF V600E+ mCRC

Updated data from the phase 3 BREAKWATER trial showed that combining Braftovi (encorafenib) and Erbitux (cetuximab) with mFOLFOX6 chemotherapy (modified fluorouracil, leucovorin and oxaliplatin) elicited a statistically significant and clinically …

Source: Cure Today - Neutral
Published on May 27, 2025

ASCO 25: Merus bispecific scores again in HNSCC

For the second year running, data at ASCO on Merus' bispecific antibody petosemtamab in head and neck cancer has drawn the eye, as the company talks up its potential to become a new standard of care. The results show an impressive 63% objective …

Source: pharmaphorum - Neutral
Published on 03:13 GMT

Triplet therapy significantly improves survival in BRAF V600E-mutated metastatic colorectal cancer

First-line treatment with the triplet combination of encorafenib, cetuximab and mFOLFOX6 significantly improved survival compared to the standard of care in patients with BRAF V600E-mutated metastatic colorectal cancer, according to new data from the Phase …

Source: Medical News - Neutral
Published on May 30, 2025

Tick bites and how to avoid getting them

Outdoor-loving Kentuckians know that tick bites carry risk. Many have heard that tick bites can lead to Lyme disease but did you know they can also cause a little-known allergy to red meat and other mammalian byproducts called Alpha-Gal Syndrome? …

Source: Henry County Local - Kentucky - Neutral
Published on May 30, 2025

Pfizer Reports Survival Gains In Colorectal Cancer Study, Combo Therapy Cuts Death Risk By Over 50%

Pfizer Inc. PFE on Friday released data from Phase 3 BREAKWATER trial evaluating BRAFTOVI (encorafenib) in combination with cetuximab (marketed as ERBITUX) and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) for metastatic colorectal cancer (mCRC) …

Source: Benzinga - Neutral
Published on May 30, 2025

ASCO25: Pfizer’s Braftovi combo boasts 47% drop in disease progression in mCRC

Pfizer’s Braftovi (encorafenib) combination therapy was shown to reduce the risk of death by nearly half compared to standard of care (SOC) for metastatic colorectal cancer (mCRC) patients with BRAF V600E mutation. The company announced the survival …

Source: Pharmaceutical Technology - Neutral
Published on May 30, 2025

Regimen confers ‘unprecedented’ survival benefit in BRAF-mutated advanced colorectal cancer

Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: The addition of encorafenib and cetuximab to …

Source: Healio News - Neutral
Published on May 30, 2025

ASCO: Triple Therapy Regimen Significantly Improves Survival in BRAF V600E-Mutated Metastatic Colorectal Cancer

Approximately 8 to 12% of patients with colorectal cancer have BRAF mutations Treatment with the triplet combination of drugs – encorafenib, cetuximab and chemotherapy – helped patients live longer and kept cancer from progressing The Food and Drug …

Source: Newswise - Neutral

02 days 08:32:44

Featured Releases

Got News to Share? · Submit · See All

Published on May 31, 2025 - 11:07 GMT

URGN CLASS ACTION NOTICE: UroGen Pharma Ltd. has been Sued for Securities Fraud after Stock Plummets 45% – Contact BFA ...

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) and certain of the Company’s senior executives for potential violations …

Distribution channels: Consumer Goods, Law ...
Published on May 30, 2025 - 12:48 GMT

Nasal Polyposis Drugs Market Size, Trends & Top Treatment Options 2025 | DataM Intelligence

The Global Nasal Polyposis Drugs Market is estimated to reach at a CAGR of 6.6% during the forecast period 2024-2031. AUSTIN, TX, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Market Overview: The Global Nasal Polyposis Drugs Market is expanding …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 30, 2025 - 12:45 GMT

IgA Nephropathy Drugs Market to Grow at 18.1% CAGR Driven by Biologic Innovations and FDA Approvals| DataM Intelligence

The IgA Nephropathy drugs market is set for 18.1% CAGR growth, led by biologics, FDA approvals, and major pharma R&D efforts worldwide. NEW YORK, NY, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Market Overview: The IgA Nephropathy …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 12:30 GMT

Prescription Drugs Market to Reach USD 2.15 Trillion by 2031, Driven by Innovation and Demand | DataM Intelligence

Prescription drug market expands rapidly due to AI in pharma, rising diseases, and global access to advanced therapies. AUSTIN, TX, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- The global prescription drugs market is experiencing robust …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 30, 2025 - 23:35 GMT

Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp.

TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Jack Burnett ("CEO") today announced that he has filed an early warning report (the "Early Warning Report") under National Instrument 62-103 – The Early Warning System and Related Take-Over Bid …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 20:01 GMT

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 28, 2025 - 18:00 GMT

BestRx Pharmacy Software Announces Integration with Lansworth Pharma SelfServe’s Pharmaself24 Kiosk Solution

BestRx is pleased to announce a new integration with Lansworth Pharma SelfServe, an advanced automated prescription pickup solution. OAKBROOK, IL, UNITED STATES, May 28, 2025 /⁨EINPresswire.com⁩/ -- BestRx, a RedSail Technologies company and a leading …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 19:44 GMT

URGN Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against UroGen Pharma Ltd.

SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025. …

Distribution channels: Consumer Goods, Law ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 817,897,982 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 31, 2025 - 15:15 GMT

San Francisco Dental Implant Center Announces New Content on Convenient Dental Implant Locations in SF

San Francisco Dental Implant Center, a top dental implant center in San Francisco, California, is proud to announce new content focusing on convenient location. SAN FRANCISCO, CA, UNITED STATES, May 31, 2025 /⁨EINPresswire.com⁩/ -- San Francisco …

Distribution channels: Building & Construction Industry, Consumer Goods ...
Published on May 31, 2025 - 12:04 GMT

Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell ...

Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001) Libtayo also demonstrated 80% and 65% reductions in the risk of locoregional and distant recurrence, respectively, compared to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 31, 2025 - 12:00 GMT

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/...

Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 31, 2025 - 00:00 GMT

The Good Feet Store Opens in Seabrook, NH to Help Local Residents and Workforce Live the Life They Love

The Leading Retailer of Premium, Personally-Fitted Arch Supports Expands with the Tenth Store in the Boston Area SEABROOK, NH, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- The Good Feet Store, recognized nationally as the market-leading …

Distribution channels: Companies, Consumer Goods ...
Published on May 31, 2025 - 00:00 GMT

Nurses for Natural Health Hosts Transformative Yoga Retreat for Nurses in France

PHOENIX , AZ, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- This July, Nurses for Natural Health invites nurses from around the world to join a one-of-a-kind restorative yoga retreat in the picturesque town of Luz-Saint-Sauveur. Designed to …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on May 31, 2025 - 12:00 GMT

Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated incidence and mortality in a high-risk population Data …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 31, 2025 - 12:00 GMT

Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in ...

Phase III NAPOLI 3 trial is the largest and has the longest follow-up for an interventional study in metastatic pancreatic adenocarcinoma1 Post-hoc analysis of NAPOLI 3 study determined characteristics associated with long-term survival, with median …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 31, 2025 - 12:00 GMT

Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with ...

26% preliminary objective response rate observed in heavily pre-treated patients with metastatic microsatellite stable colorectal cancer (MSS CRC) without liver metastases Deep and durable responses ongoing for up to 37 weeks through the data cutoff, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 31, 2025 - 12:00 GMT

Une analyse « Late Breaking » démontre les caractéristiques associées à la survie globale à long terme des patients avec ...

L’essai de Phase III NAPOLI 3 est la plus grande étude interventionnelle réalisée à ce jour avec la plus longue période de suivi des patients avec un adénocarcinome pancréatique métastatique1. L’analyse post-hoc de l’étude NAPOLI 3 a permis de déterminer …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 22:30 GMT

From protocol to empathetic accompaniment: improving dialysis care via psychological education

A groundbreaking shift is happening in the treatment of chronic kidney disease thanks to the work of psychologist Mrs. Erika Danitza Rocabado Vargas. RICHMOND, VA, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- With over 19 years of clinical …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 30, 2025 - 21:46 GMT

NYC Optician French Optical Fashion, Inc. Educates on Eye Wellness

French Optical Fashion, Inc. launches NYC optician campaign to promote eye health with exams and education. NEW YORK, NY, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- French Optical Fashion, Inc., a premier NYC optician located at 7 East …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 21:45 GMT

BREAST CANCER ALLIANCE AWARDS $1.3M IN GRANTS TO ADVANCE RESEARCH, BREAST SURGICAL ONCOLOGY TRAINING, AND ACCESS TO CARE

GREENWICH, CT, CT, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Breast Cancer Alliance (BCA), one of the nation’s leading and most impactful nonprofit breast cancer organizations, proudly announces the awarding of $1.3 million in 2025 grants …

Distribution channels: Beauty & Hair Care, Education ...
Published on May 30, 2025 - 21:17 GMT

New Book Reveals the Overlooked Toxins Impacting American Homes

A shocking exposé reveals how everyday home materials harm your family—and the proven steps to detox, protect, and rebuild your health. ORLANDO, FL, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- What if the place you trust the most is …

Distribution channels: Agriculture, Farming & Forestry Industry, Book Publishing Industry ...
Published on May 30, 2025 - 20:39 GMT

Meaningful Life Counseling Pioneers Early Couples Therapy in CT for Lasting Love

Meaningful Life Counseling in CT promotes early couples therapy to strengthen relationships, offering free consultations to help partners thrive. WOODBRIDGE, CT, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- As couples face mounting …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 20:00 GMT

Mobility City Holdings Inc Celebrates Six Years of Serving People in Lake County Illinois & Surrounding Communities

Kevin Pignone opened his showroom in Grayslake IL with a mission to help people with mobility challenges via the repair, rental and sale of mobility equipment BOCA RATON, FL, US, May 30, 2025 /⁨EINPresswire.com⁩/ -- Mobility City Holdings, Inc., …

Distribution channels: Business & Economy, Companies ...
Published on May 30, 2025 - 19:45 GMT

Free Training Event During CPR and AED Awareness Week Aims to Equip More People to Act in Emergencies

Hands-on virtual session June 6 empowers participants with the skills and confidence to respond in cardiac emergencies—no experience required. HOUSTON, TX, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- In an effort to empower more …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 30, 2025 - 19:15 GMT

LosAngelesMedicalMalpracticeLawyers.com Launches to Connect Individuals with Malpractice Lawyers

LOS ANGELES, CA, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- A new website, losangelesmedicalmalpracticelawyers.com, has been launched to assist individuals in the Los Angeles area in finding the best medical malpractice lawyer for their …

Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
Published on May 30, 2025 - 19:00 GMT

A New Initiative for the Wellness of Children and Communities: A Mental Health Awareness Event with U.S. - Japan Experts

～Heartfulness × Hip-Hop Therapy × Expressive Arts Therapy ～“M.O.F.U.” to Be Held for the First Time in Katsushika, Tokyo TOKYO, CA, JAPAN, May 30, 2025 /⁨EINPresswire.com⁩/ -- On Saturday, June 7, 2025, a mental health awareness event titled“M.O.F …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 30, 2025 - 18:40 GMT

Media Statement By Dr. Gail C. Christopher: America 5 Years After George Floyd’s Murder

Dr. Christopher, leader of the National Collaborative for Health Equity, says racial justice faces headwinds, but accomplishments have not been erased WASHINGTON, DC, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Five years ago, at the …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 30, 2025 - 18:28 GMT

Cosmetic Dentistry Experts Drs. John and Jade Moreau of Unforgettable Smiles Talk How Enhanced Smiles Build Confidence

ALEXANDRIA, LA, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Drs. John and Jade Moreau of Unforgettable Smiles is featured in the latest edition of HelloNation, where he shares valuable insight on the role of cosmetic dentistry in improving both …

Distribution channels: Beauty & Hair Care, Business & Economy ...